In addition, assessment of the projected glycemic effectiveness associated with oral semaglutide based on trial data indicated that 62% of patients would achieve an HbA1c level below 7%, and 43% would achieve their optimal individualized HbA1c target
Patients should seek urgent medical attention for severe abdominal pain, bloody diarrhoea, persistent vomiting, or signs of dehydration
In adults with obesity, daily subcutaneous administration of 3.0 mg liraglutide in combination with lifestyle therapy results in a reduction in body weight of approximately 8%
Ogden CL, Fakhouri TH, Carroll MD, Hales CM, Fryar CD, Li X, et al
Vitamin A is important for skin turnover and renewal, Lavalle says
Oxidative stress in bone remodeling: role of antioxidants